ERF and posterior cortical atrophy: A limitation of this targeted approach in PCa patients is that we did not find a statistically significant difference in ETV1 transcript levels in CIC-ERF co-deleted tumors compared to CIC-ERF replete tumors in the TCGA-PRAD (n=455) dataset.